Bayer rules out increasing bid for Schiff Nutrition

German chemicals and pharmaceuticals giant Bayer withdrew from a battle to buy US-based Schiff Nutrition International on Tuesday, ruling out an increase to its bid against a rival counter offer.

The company's board "continues to believe that the merger transaction would represent a logical and strategic addition for 's Consumer Care business", it said in a statement on the internet site of the US (SEC).

But it added that it had come to the conclusion that entering a competitive bidding process "would result in a price outside Bayer's set financial criteria".

Last week, Britain's Reckitt Benckiser made a higher offer than Bayer's bid for Schiff Nutrition, a leading maker of vitamins and .

Bayer said on October 30 that it had agreed to buy Schiff Nutrition in a deal worth $1.2 billion (920 million euros).

The British group's offer valued the company at $1.4 billion.

A spokeswoman for Bayer declined to comment further due to legal reasons.

Schiff Nutrition, based in , Utah, has a workforce of some 400 and generated sales of $259 million in its business year ended May 31.


Explore further

Bayer unveils a faster-acting aspirin

(c) 2012 AFP

Citation: Bayer rules out increasing bid for Schiff Nutrition (2012, November 20) retrieved 28 May 2022 from https://phys.org/news/2012-11-bayer-schiff-nutrition.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors